City National Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

City National Bank’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$5.76M	Sell	86,079 -34,667	-29%	-$2.83M	0.05%	239
2015 Q2	$11.7M	Sell	120,746 -4,822	-4%	-$459K	0.1%	195
2015 Q1	$11.7M	Buy	125,568 +27,642	+28%	+$2.35M	0.1%	195
2014 Q4	$8.71M	Buy	97,926 +7,159	+8%	+$521K	0.08%	225
2014 Q3	$6.27M	Sell	90,767 -2,299	-2%	-$123K	0.06%	245
2014 Q2	$5.34M	Buy	93,066 +26,852	+41%	+$1.36M	0.05%	259
2014 Q1	$2.63M	Buy	66,214 +13,889	+27%	+$594K	0.04%	273
2013 Q4	$2.19M	Buy	+52,325	New	+$1.52M	0.03%	295

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

City National Bank's MACK Position: Q3 2015 in Review

City National Bank reduced its Merrimack Pharmaceuticals, Inc. (MACK) stake by 29% in Q3 2015, selling an estimated $2.83M and leaving 86,079 shares worth $5.76M. The position accounts for 0.05% of the portfolio, ranked #239.

City National Bank first reported a position in MACK in Q4 2013 and has held it in 8 quarters since. The position peaked at $11.7M in Q2 2015. 135 funds tracked by Wall St. Rank hold MACK as of Q3 2015.

City National Bank held 86,079 shares of Merrimack Pharmaceuticals, Inc. worth $5.76M as of Q3 2015.
City National Bank sold 34,667 Merrimack Pharmaceuticals, Inc. shares in Q3 2015, an estimated $2.83M.
Merrimack Pharmaceuticals, Inc. made up 0.05% of City National Bank's portfolio in Q3 2015, its #239 holding.
City National Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2013 and has held it in 8 quarters since.
City National Bank's Merrimack Pharmaceuticals, Inc. position peaked at $11.7M in Q2 2015.
135 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.